Caution Advised as Common Painkillers Linked to Kidney Damage Risks

Emily Watson, Health Editor
5 Min Read
⏱️ 4 min read

**

As the use of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen becomes increasingly common for pain relief, health experts are warning of the potential risks they pose to kidney function. Particularly concerning is the elevated blood pressure these medications can cause, which may lead to damage within the blood vessels of the kidneys. This caution comes from organisations such as Kidney Care UK and the National Pharmacy Association (NPA), emphasising the importance of awareness, especially among those at higher risk of kidney disease.

Understanding the Risks of NSAIDs

The NPA and Kidney Care UK have issued a strong warning for individuals who regularly utilise NSAIDs for pain management. These medications, while effective for alleviating discomfort, can have serious repercussions for kidney health, particularly in vulnerable populations.

Individuals with pre-existing conditions such as diabetes, hypertension, or a family history of kidney disease should exercise particular caution. Olivier Picard, chair of the NPA, remarked, “Medicines have the power to harm as well as to heal. Although NSAIDs, such as ibuprofen, are effective and safe medicines, patients should be aware of their impact—particularly if they are at an increased risk of developing kidney disease.”

For those concerned about using these drugs, consulting a pharmacist for advice is strongly recommended. Pharmacists possess the expertise to guide patients on the safe use of medications and to help them explore alternative pain relief options.

The Prevalence of Kidney Disease

In the UK, approximately 7.2 million individuals are living with some form of chronic kidney disease, often without any symptoms in the initial stages. Alarmingly, Kidney Care UK estimates that around one million people remain undiagnosed, heightening the urgency for awareness about kidney health.

Certain demographics are at a greater risk of developing kidney issues, including those with diabetes, high blood pressure, a family history of kidney disease, and individuals from Black and South Asian communities. Fiona Loud, policy director at Kidney Care UK, highlighted the universal threat of kidney disease, stating, “Kidney disease can happen to anyone at any time and can have a devastating impact on your life, relationships, finances as well as your physical and mental health.”

The Importance of Monitoring Kidney Health

Recent data reveals that nearly 24% of individuals who completed Kidney Care UK’s online kidney health checker between October 2024 and March 2026 reported regular use of over-the-counter medications for pain relief. This statistic underscores the critical need for ongoing monitoring of kidney health, particularly for those using NSAIDs frequently.

Loud further emphasised the silent nature of kidney disease, noting, “You can lose up to 90% of your kidney function without realising, so it’s important to be aware of the signs to look out for, to know if you might be at increased risk, and what to do if you are concerned.” Completing an online kidney health assessment can be a useful first step for individuals to better understand their risk.

Seeking Guidance from Healthcare Professionals

If individuals suspect they may be at risk for kidney disease or have concerns regarding their use of pain relief medications, they are encouraged to speak with their general practitioner or local pharmacist. Engaging with healthcare professionals can ensure that patients receive tailored advice and support in managing their health effectively.

Why it Matters

Understanding the implications of common painkillers like ibuprofen is vital for protecting kidney health, especially among those at risk. As chronic kidney disease often develops without noticeable symptoms, raising awareness and promoting proactive health monitoring can significantly alter outcomes for millions. By encouraging cautious use of NSAIDs and facilitating access to expert advice, we can help safeguard the health of individuals and communities, ultimately reducing the burden of kidney disease across the nation.

Share This Article
Emily Watson is an experienced health editor who has spent over a decade reporting on the NHS, public health policy, and medical breakthroughs. She led coverage of the COVID-19 pandemic and has developed deep expertise in healthcare systems and pharmaceutical regulation. Before joining The Update Desk, she was health correspondent for BBC News Online.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy